Effect of interferon-γ on inflammatory cytokine-induced bradykinin B1 receptor expression in human vascular cells

European Journal of Pharmacology

Volumn 647, Issue 1-3, 2010, Pages 117-125

  Koumbadinga, Gérémy Abdull ^a   Désormeaux, Anick ^b   Adam, Albert ^b   Marceau, François ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Bradykinin B1 receptor; Endothelial cell; Interferon ; Smooth muscle cell; Tumor necrosis factor

Indexed keywords

[5 (4 FLUOROPHENYL) 2 UREIDO]THIOPHENE 3 CARBOXAMIDE; BRADYKININ B1 RECEPTOR; ETANERCEPT; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; GAMMA INTERFERON RECEPTOR; I KAPPA B KINASE INHIBITOR; JANUS KINASE; MESSENGER RNA; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BINDING ASSAY; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG TARGETING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; QUANTITATIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UMBILICAL ARTERY SMOOTH ENDOTHELIAL CELL; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VASCULAR ENDOTHELIUM;

ANTINEOPLASTIC AGENTS; CYTOKINES; DNA-BINDING PROTEINS; ENDOTHELIAL CELLS; HUMANS; INTERFERON-GAMMA; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; RECEPTORS, INTERFERON; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL CORD; UP-REGULATION;

EID: 77957311572     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.08.008     Document Type: Article

References (28)

1. 1 receptor mediates inhibition of neointima formation in rat artery after balloon angioplasty. Hypertension 2000, 36:364-370.
2. 1 receptor gene promoter: no modification on interleukin-1 beta or lipopolysaccharide induction. J. Cell. Biochem. 2000, 78:278-296.
3. 2 receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates. J. Pharmacol. Exp. Ther. 2001, 297:19-26.
4. De Kimpe S.J., Tielemans W., Van Heuven-Nolsen D., Nijkamp F.P. Reversal of bradykinin-induced relaxation to contraction after interferon- γ in bovine isolated mesenteric arteries. Eur. J. Pharmacol. 1994, 261:111-120.
5. Deo D.D., Axelrad T.W., Robert E.G., Marcheselli V., Bazan N.G., Hunt J.D. Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-asctivating factor, Jak-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism. J. Biol. Chem. 2002, 277:21237-21245.
6. 1 receptors in cultured cells. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H1647-H1654.
7. Gough D.J., Levy D.E., Johnstone R.W., Clarke C.J. IFNγ signaling-does it mean JAK-STAT?. Cytokine Growth Factor Rev. 2008, 19:383-394.
8. 2 receptor. Hypertension 2000, 35:1319-1325.
9. Huot J., Houle F., Marceau F., Landry J. Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ. Res. 1997, 80:383-392.
10. 1 receptors stimulate nitric oxide production in endothelial cells: signaling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands. Mol. Pharmacol. 2004, 66:1310-1316.
11. Kahn R., Hellmark T., Leeb-Lundberg L.M., Akbari N., Todiras M., Olofsson T., Wieslander J., Christensson A., Westman K., Bader M., Müller-Esterl W., Karpman D. Neutrophil-derived proteinase 3 induces kallikrein-independent release of a novel vasoactive kinin. J. Immunol. 2009, 182:7906-7915.
12. Karczewski M., Karczewski J., Poniedzialek B., Wiktorowicz K., Glyda M. Cytometric analysis of TH1/TH2 cytokines in the urine of patients undergoing kidney transplantation. Ann. Transplant. 2009, 14:25-28.
13. 1 receptor expression in rabbit aortic smooth muscle. Eur. J. Pharmacol. 2009, 606:233-239.
14. Leeb-Lundberg L.M.F., Marceau F., Müller-Esterl W., Pettibone D.J., Zuraw B.L. International Union of Pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 2005, 57:27-77.
15. Liesmaa I., Kuoppala A., Shiota N., Kokkonen J.O., Kostner K., Mäyränpää M., Kovanen P.T., Lindstedt K.A. Increased expression of bradykinin type-1 receptors in endothelium of intramyocardial coronary vessels in human failing hearts. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H2317-H2322.
16. 2 bradykinin receptor mRNA and membrane receptors by IFNγ. Immunopharmacology 1998, 39:243-253.
17. 1 receptors for kinins. Pharmacol. Rev. 1998, 50:357-386.
18. 1 receptor in human vascular smooth muscle cells. Mol. Pharmacol. 2007, 71:949-956.
19. 1 receptor: role of receptor density and released mediators. Can. J. Physiol. Pharmacol. 2006, 84:1107-1119.
20. Raidoo D.M., Ramsaroop R., Naidoo S., Müller-Esterl W., Bhoola K.D. Kinin receptors in human vascular tissue: their role in atheromatous disease. Immunopharmacology 1997, 36:153-160.
21. Sabourin T., Guay K., Houle S., Bouthillier J., Bachvarov D.R., Adam A., Marceau F. Absence of ligand-induced regulation of kinin receptor expression in the rabbit. Br. J. Pharmacol. 2001, 133:1154-1162.
22. 1 receptor in fresh or cultured rabbit aortic smooth muscle: role of NF-κB. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H227-H237.
23. Sierra-Honigmann M.R., Nath A.K., Murakami C., Garcia-Cardena G., Papapetropoulos A., Sessa W.C., Madge L.A., Schechner J.S., Schwabb M.B., Ploverini P.J., Flores-Riveros J.R. Biological action of leptin as an angiogenic factor. Science 1998, 281:1683-1686.
24. Skurkovich S., Skurkovich B. Anticytokine therapy, especially anti-interferon-γ, as a pathogenetic treatment in TH-1 autoimmune diseases. Ann. NY Acad. Sci. 2005, 1051:684-700.
25. Song H., Wang R., Wang S., Lin J. A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells. Proc. Nat. Acad. Sci. U.S.A. 2005, 102:4700-4705.
26. Strnad J., Burke J.R. IκB kinase inhibitors for treating autoimmune and inflammatory disorders: potential and challenges. Trends Pharmacol. Sci. 2007, 28:142-148.
27. Taleb S., Tedgui A., Mallat Z. Adaptive T cell immune responses and atherogenesis. Curr. Opin. Pharmacol. 2010, 10:197-202.
28. Tallarida R.J., Murray R.B. Manual of Pharmacologic Calculations with Computer Programs 1987, Springer-Verlag, New York, NY.